172 related articles for article (PubMed ID: 11323565)
1. [Primary hyperparathyroidism in patients treated for non-medullary thyroid carcinoma].
Rubello D; Pagetta C; Pelizzo MR; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):31-4. PubMed ID: 11323565
[TBL] [Abstract][Full Text] [Related]
2. Importance of careful Tc-MIBI interpretation in patients with thyroid cancer and primary hyperparathyroidism.
Lee KA; Jin HY; Baek HS; Park TS
Korean J Intern Med; 2015 Jul; 30(4):556-7. PubMed ID: 26161027
[No Abstract] [Full Text] [Related]
3. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
Rubello D; Saladini G; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
[TBL] [Abstract][Full Text] [Related]
4. Cystic parathyroid adenoma: Primary hyperparathyroidism without
Oliver Guillén JR; de la Cueva Barrao L; Miguelena Bobadilla JM; Giménez Maurel T; Hernando Almudí E; Casamayor Franco MC
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):254-256. PubMed ID: 28392334
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cancer detection with dual-isotope parathyroid scintigraphy in primary hyperparathyroidism.
Onkendi EO; Richards ML; Thompson GB; Farley DR; Peller PJ; Grant CS
Ann Surg Oncol; 2012 May; 19(5):1446-52. PubMed ID: 22395991
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
7. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
8. Sestamibi scintigraphy for parathyroid localisation: a reminder of the dangers of false positives.
Whitcroft KL; Sharma A
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24618871
[TBL] [Abstract][Full Text] [Related]
9. The role of total thyroidectomy in the management of differentiated thyroid cancer.
Stephenson BM; Wheeler MH; Clark OH
Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
[TBL] [Abstract][Full Text] [Related]
11. Intrathyroid parathyroid adenoma potentially mimicking a parathyroid carcinoma.
Rubello D; Armigliato M; Rampin L; Massaro A; Cittadin S; Pelizzo MR; Menaldo G; Muzzio PC; Gross MD
Minerva Endocrinol; 2006 Sep; 31(3):247-8. PubMed ID: 17213791
[No Abstract] [Full Text] [Related]
12. An association of primary hyperparathyroidism and non medullary thyroid carcinoma.
Bisbocci D; Gambino M; Modina P; Livorno P; Ossola M; Marinone C; Pellerito R; Cottino F
Recenti Prog Med; 1991 May; 82(5):272-4. PubMed ID: 1887151
[TBL] [Abstract][Full Text] [Related]
13. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease.
Katz SC; Wang GJ; Kramer EL; Roses DF
Am Surg; 2003 Feb; 69(2):170-5. PubMed ID: 12641362
[TBL] [Abstract][Full Text] [Related]
14. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
Taillefer R; Boucher Y; Potvin C; Lambert R
J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
[TBL] [Abstract][Full Text] [Related]
15. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of 99mTc-methoxy-isobutyl-isonitrile scintigraphy for preoperative localization of adenoma in primary hyperparathyroidism].
Yamaguchi S; Kobayashi Y; Tsujikawa K; Noma M; Mori N; Hara T; Takao T; Takada S; Sugao H; Yoshida S
Hinyokika Kiyo; 2001 Sep; 47(9):619-23. PubMed ID: 11692597
[TBL] [Abstract][Full Text] [Related]
17. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement.
Goldstein RE; Billheimer D; Martin WH; Richards K
Ann Surg; 2003 May; 237(5):722-30; discussion 730-1. PubMed ID: 12724639
[TBL] [Abstract][Full Text] [Related]
18. [Radio-guided parathyroidectomy. A prospective study in 54 patients with primary hyperparathyroidism].
Pelizzo MR; Piotto A; Rubello D; Piazzolla P; Merante Boschin I; Toniato A; Bernante P; Bergamasco A; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):35-9. PubMed ID: 11323566
[TBL] [Abstract][Full Text] [Related]
19. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
20. Concomitant hyperparathyroidism and nonmedullary thyroid cancer, with a review of the literature.
Leitha T; Staudenherz A
Clin Nucl Med; 2003 Feb; 28(2):113-7. PubMed ID: 12544127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
